$RNN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Ocuphire Pharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Ocuphire Pharma, Inc.. Get notifications about new insider transactions in Ocuphire Pharma, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 03 2006 | RNN | REXAHN PHARMACEUTI ... | Ahn Inok | Director | Option Exercise | A | 0.80 | 500,000 | 400,000 | 500,000 | |
May 03 2006 | RNN | REXAHN PHARMACEUTI ... | Ahn Inok | Director | Option Exercise | D | 0.25 | 500,000 | 125,000 | 0 | |
May 03 2006 | RNN | REXAHN PHARMACEUTI ... | Cheong Kwang Soo | Director | Option Exercise | A | 1.20 | 20,000 | 24,000 | 20,000 | |
May 03 2006 | RNN | REXAHN PHARMACEUTI ... | Kang Y Michele | Director | Option Exercise | A | 1.20 | 20,000 | 24,000 | 20,000 | |
May 03 2006 | RNN | REXAHN PHARMACEUTI ... | Beever Charles | Director | Option Exercise | A | 1.20 | 20,000 | 24,000 | 20,000 | |
May 17 2005 | RNN | REXAHN PHARMACEUTI ... | HOLADAY JOHN W DR | Director | Option Exercise | A | 0.24 | 125,000 | 30,000 | 125,000 | |
May 17 2005 | RNN | REXAHN PHARMACEUTI ... | HOLADAY JOHN W DR | Director | Option Exercise | A | 0.24 | 100,000 | 24,000 | 100,000 | |
May 17 2005 | RNN | REXAHN PHARMACEUTI ... | Steinfels George F | Chief Business Offi ... | Option Exercise | A | 0.24 | 500,000 | 120,000 | 500,000 | |
May 17 2005 | RNN | REXAHN PHARMACEUTI ... | Steinfels George F | Chief Business Offi ... | Option Exercise | A | 0.24 | 250,000 | 60,000 | 250,000 | |
May 17 2005 | RNN | REXAHN PHARMACEUTI ... | McIntosh David M | Director | Option Exercise | A | 0.24 | 125,000 | 30,000 | 125,000 | |
May 17 2005 | RNN | REXAHN PHARMACEUTI ... | Rhee Jang Han | Director | Grant | A | 0.00 | 2,000,000 | 0 | 2,000,000 | 0 to 2 M |
May 17 2005 | RNN | REXAHN PHARMACEUTI ... | Kwon Suk Hyung | Director | Grant | A | 0.00 | 114,255 | 0 | 114,255 | 0 to 114.3 K |
May 17 2005 | RNN | REXAHN PHARMACEUTI ... | Kwon Suk Hyung | Director | Grant | A | 0.00 | 2,096,000 | 0 | 2,096,000 | 0 to 2.1 M |
May 17 2005 | RNN | REXAHN PHARMACEUTI ... | Jeong Tae Heum | CFO and Secretary | Option Exercise | A | 0.24 | 500,000 | 120,000 | 500,000 | |
May 17 2005 | RNN | REXAHN PHARMACEUTI ... | Jeong Tae Heum | CFO and Secretary | Option Exercise | A | 0.24 | 250,000 | 60,000 | 250,000 | |
May 17 2005 | RNN | REXAHN PHARMACEUTI ... | Jeong Tae Heum | CFO and Secretary | Grant | A | 0.00 | 500,000 | 0 | 500,000 | 0 to 500 K |
Jan 13 2005 | RNN | REXAHN PHARMACEUTI ... | Ferraro Frank | Director | Sell | S | 0.00 | 10,000,000 | 18,000 | 0 | 10 M to 0 (-100.00 %) |
Jan 13 2005 | RNN | REXAHN PHARMACEUTI ... | Ferraro Frank | Director | Sell | S | 0.00 | 224,000,000 | 403,200 | 26,000,000 | 250 M to 26 M (-89.60 %) |